back to Blog

Acceleron adds 2 new sites for ACE-083 clinical trial

Posted on January 30th, 20171/30/17

Cambridge, Massachusetts-based Acceleron Pharma, Inc., is now recruiting adults with FSH muscular dystrophy for a Phase 2 clinical trial of ACE-083 at sites in Kansas City, KS, and Rochester, NY, in addition to St. Louis, MO. For more information, visit our page “Find a Clinical Study.”

Correction: In our email alert, we mentioned Cleveland, OH, as a future trial site. The correct location is Columbus, OH.

Share
Filed under: FSHD Research

2 responses to “Acceleron adds 2 new sites for ACE-083 clinical trial”

  1. Nicholas Esposito says:
    March 4, 2017 at 6:49 pm

    You should do a study near Hickory, NC. I am a fitness fanatic and would love to test this out.

    • June Kinoshita says:
      March 4, 2017 at 9:53 pm

      As it happens, Acceleron has opened a trial site for ACE-083 in Charlotte. Check clinicaltrials.gov for details.
      P.S. We were just in Hickory last week! Wish we had known.